Novo Nordisk CEO: The widespread adoption of Wegovy oral tablets fully justifies the price reduction
Show original
Glonghui, February 4th｜Novo Nordisk (NVO.US) CEO: We do not consider the pricing strategy for Wegovy oral tablets to be a gamble. We believe it is our responsibility to ensure that everyone in need has access to the medicines we produce. The widespread adoption of Wegovy oral tablets fully justifies the price reduction.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Virginia is advancing a bill to establish a strategic Bitcoin and cryptocurrency reserve fund.
Cointime•2026/02/05 14:21
Eight EU-regulated companies including Securitize warn that the EU may fall behind the US in tokenization regulations
ForesightNews•2026/02/05 14:11
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$70,268.8
-6.33%
Ethereum
ETH
$2,081.99
-5.19%
Tether USDt
USDT
$0.9993
+0.06%
BNB
BNB
$682.88
-8.03%
XRP
XRP
$1.37
-11.94%
USDC
USDC
$1
+0.08%
Solana
SOL
$90.18
-4.38%
TRON
TRX
$0.2790
-1.82%
Dogecoin
DOGE
$0.09970
-5.42%
Bitcoin Cash
BCH
$508.27
-2.69%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now